zanamivir has been researched along with Respiratory Syndrome, Acute, Severe in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araujo-Meléndez, J; Beigel, JH; Galindo-Fraga, A; Gamiño-Arroyo, AE; García-Andrade, LA; Guerrero, ML; Holley, HP; Hunsberger, S; Ibarra-González, V; Kapushoc, H; Llamosas-Gallardo, B; Martínez-López, J; McCarthy, S; Moreno-Espinosa, S; Ramírez-Venegas, A; Roldán-Aragón, Y; Ruiz-Palacios, GM; Smolskis, MC | 1 |
Eng, P; Lam, WK; Liam, CK; Seto, WH; Shim, YS; Tsang, KW; Wong, TK | 1 |
1 trial(s) available for zanamivir and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Double-Blind Method; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitro Compounds; Oseltamivir; Severe Acute Respiratory Syndrome; Thiazoles; Treatment Outcome; Young Adult; Zanamivir | 2019 |
1 other study(ies) available for zanamivir and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
Possible case scenarios and logistic issues in H5N1 pandemic.
Topics: Antiviral Agents; Disease Outbreaks; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; Severe Acute Respiratory Syndrome; Zanamivir | 2006 |